mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.1 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |